Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript
Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2026 Earnings Call Transcript May 6, 2026Castle Biosciences, Inc. reports earnings inline with expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 647,391 | $15,440,275 | 0.1% | |
| 2. | AIGH Investment Partners Orin Hirschman | 545,101 | $13,000,659 | -8% | 0.82% |
| 3. | Renaissance Technologies Jim Simons | 371,200 | $8,853,120 | -31% | 0.01% |
| 4. | Point72 Asset Management Steve Cohen | 357,317 | $8,522,010 | 0.01% | |
| 5. | Portolan Capital Management George Mccabe | 328,818 | $7,842,309 | -76% | 0.29% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.27 | 2,500 | $43,175.00 | 9,065 | 2023-06-05 | Filing | |
| $11.23 | 2,300 | $25,829.00 | 6,565 | 2023-06-05 | Filing | |
| $21.50 | 1,162 | $24,983.00 | 2,968 | 2022-11-29 | Filing | |
| $18.77 | 220 | $4,129.40 | 1,806 | 2022-05-12 | Filing | |
| $18.76 | 1,100 | $20,636.00 | 1,586 | 2022-05-12 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.33 | 2,718 | $96,037.81 | 9,550 | 2026-09-21 | Filing | |
| $35.33 | 3,198 | $112,998.13 | 11,236 | 2026-09-21 | Filing | |
| $35.33 | 8,580 | $303,165.72 | 21,479 | 2026-09-21 | Filing | |
| $35.14 | 3,294 | $115,757.75 | 58,584 | 2026-09-15 | Filing | |
| $32.32 | 3,306 | $106,863.14 | 61,878 | 2026-09-14 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,291,963 | $78,513,319 | 0% | |
| 2. | 2,778,335 | $66,263,290 | 0.57% | |
| 3. | 1,726,648 | $41,180,555 | 0.02% | |
| 4. | 1,226,497 | $29,251,953 | 0% | |
| 5. | 879,258 | $20,970,303 | 0.02% |